Latest Ophthalmology Headlines
Co-Management of Patients with Multiple Myeloma Experiencing Treatment-Related Keratopathy
Belantamab mafodotin is an experimental antibody-drug conjugate that targets B-cell maturation antigen that initially showed activity as a single...
Latest Medical Headlines
ASH Issues Guidelines on Newly Diagnosed AML in Older Adults
WEDNESDAY, Aug. 12, 2020 (HealthDay News) -- In evidence-based guidelines issued by the American Society of Hematology and published in the Aug. 11 issue...
Trending Titles from #ASCO20: NSCLC, Early-Onset CRC, and more
The ASCO20 Virtual Education Program took place Aug. 8–10. Here are some of the trending titles that have people talking.
Targeting Early-Onset Colorectal Cancer
Although colorectal...
Virtual Preoperative Planning Improves Mortality in Common Hip Fracture
An estimated 300,000 hip fractures occur in the U.S. each year—a number that is expected to double with the aging population. About half of...
COVID-19 Update: US Government Reaches Vaccine Deal with Moderna; UK Plummets Into Recession; and...
World News:
Five months since officially being declared a global pandemic by the World Health Organization (WHO), SARS-CoV-2 (COVID-19) has spread like wildfire, devastating economies...
Atrial Fibrillation Is Less Deadly Than It Used To Be: Study
A new analysis suggests that atrial fibrillation (AFib), while still a serious heart condition, has seen a decline in fatalities related to AFib over...
Advertisement
Today's Top 5
5. Physically Fit Patients More Likely to Benefit from AFib Ablation
A #newstudy shows that physically fit patients are much more likely to benefit from #AtrialFibrillation ablation, investigators in @hrs_journal report: https://t.co/o56wdOt4uq#research #HeartHealth #cardiology #arrhythmia #AF @Els_Cardiology @HRSonline pic.twitter.com/AgdJifvOEz
— Elsevier News (@ElsevierNews) August 3, 2020
4. Review of Pharmacological and Device Therapy for HRrEF
Featured in today's #DocWire Trending #Cardiology tweets: @escardio, (@Derek_Leong_RPh - for more, visit docwirenews.com and reach out to the editors @mydocwire.Comprehensive review of pharmacological and device therapy for HFrEF in @JAMA_current.https://t.co/6VAC5vuM5Y pic.twitter.com/EkYg1Pwdet
— Derek Leong (@Derek_Leong_RPh) August 10, 2020
3. The Various Ways COVID-19 Affects Heart
20/20
— European Society of Cardiology (@escardio) August 10, 2020
We hope this tweetorial has helped outline the various ways #COVID19 can affect the heart.
It would not be possible without your excellent submissions! Please continue to send your cases to #EHJCaseReports https://t.co/8yMHcBvGVk@johncamm @cfcamm #cardioed #cardiotwitter
2. Echo of the Day
Featured in today's #DocWire Trending #Cardiology tweets: @HanCardiomd, @drEdgarFuentes - for more, visit docwirenews.com and reach out to the editors @mydocwire.📌 Typical rheumatic aortic valve disease, with classical commissural fusion and thickened leaflets.#Echooftheday #3D#Echofirst @SONECOM_AC @RevEcocar @MAecocardio @mariovar55 @cardiopedhnn @jorgeachv @iamritu @SISIACOficial @lpbadano @jusalas77 @josejgdnews @VazyurVasquez pic.twitter.com/l3nuxbFh0T
— Edgar Fuentes Molina (@drEdgarFuentes) August 12, 2020
1. 2020 Expert Consensus on Therapies for CV Risk Reduction in Type 2 Diabetes Patients
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee. https://t.co/dXMopE5V3u @ACCinTouch @JACCJournals @pabeda1 @iamritu pic.twitter.com/3WtwcCIGCg
— Henry Han, MBBS, MD (@HanCardiomd) August 12, 2020